(Q36780439)

16 August 2017

1 reference

title

Origin of fatigue in multiple sclerosis: review of the literature (English)

1 reference

16 August 2017

0 references

Kos D

1

1 reference

16 August 2017

Kerckhofs E

2

1 reference

16 August 2017

Nagels G

3

1 reference

16 August 2017

D'hooghe MB

4

1 reference

16 August 2017

Ilsbroukx S

5

1 reference

16 August 2017

publication date

4 April 2007

1 reference

Neurorehabilitation and Neural Repair

16 August 2017

published in

1 reference

16 August 2017

volume

22

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

91-100

1 reference

Development of an adjective checklist to measure five FACES of fatigue and sleepiness. Data from a national survey of insomniacs

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Distinguishing between excessive daytime sleepiness and fatigue: toward improved detection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

The nature of fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

What is behind "I'm so tired"? Fatigue experiences and their relations to the quality and quantity of external stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Evaluation of the Modified Fatigue Impact Scale in four different European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Validity and reliability of a scale to assess fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

A rapid screening tool for fatigue impact in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue and magnetic resonance imaging activity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in multiple sclerosis: interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

The relationship between diffuse axonal damage and fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Association of fatigue and brain atrophy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement--EEG evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Evidence for widespread movement-associated functional MRI changes in patients with PPMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Deep gray matter and fatigue in MS: a T1 relaxation time study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in multiple sclerosis: definition, pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Cytokine mRNA expression in patients with multiple sclerosis and fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Acute interferon beta-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Side effect profile of interferon beta-1b in MS: results of an open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Review: cytokines and the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Modafinil increases histamine release in the anterior hypothalamus of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Evidence of an abnormal intramuscular component of fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Functional relationships of central and peripheral muscle alterations in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Cross-bridge mechanisms of muscle weakness in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Effects of exercise on muscle activation and metabolism in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Sleep disturbance, depression, and lesion site in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Sleep problems in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Sleep and fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

The relationship of sleep disturbances and fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

What have fatigue and sleepiness in common?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Quantitation of lower physical activity in persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Treadmill training for individuals with multiple sclerosis: a pilot randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Impact of aerobic training on fitness and quality of life in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Randomized controlled trial of yoga and exercise in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Exercise therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Effects of treatment for depression on fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Effect of pulsed magnetic field therapy on the level of fatigue in patients with multiple sclerosis--a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Contributing factors to depressed mood in Multiple Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in multiple sclerosis is related to disability, depression and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue and its association with sociodemographic variables among multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

An examination of four models predicting fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Management of fatigue in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue associated with multiple sclerosis: diagnosis, impact and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

The impact of outpatient rehabilitation on quality of life in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Cooling garment treatment in MS: clinical improvement and decrease in leukocyte NO production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

A randomized controlled study of the acute and chronic effects of cooling therapy for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Randomized controlled trial of an energy conservation course for persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Evaluation of the effectiveness of professionally guided self-care for people with multiple sclerosis living in the community: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Nutrition and diet in the clinical management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Amantadine treatment of fatigue associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Treating fatigue in patients with MS: one step forward, one step back

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545968306298934

21 January 2018

Identifiers

DOI

10.1177/1545968306298934

1 reference

16 August 2017

1 reference